Login Register Cart 0
Generic placeholder image

Current Molecular Medicine

Editor-in-Chief

ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Letter to the Editor

COVID-Toe - The Silent Symptom: Raising Awareness among Health Care Professionals and Community

Author(s): Nitesh Sanghai* and Geoffrey K. Tranmer

Volume 22, Issue 7, 2022

Published on: 04 January, 2022

Page: [563 - 566] Pages: 4

DOI: 10.2174/1566524021666211013121116

Next »
[1]
Stadler K, Rappuoli R. SARS understanding the virus and development of rational therapy. Curr Mol Med 2005; 5(7): 677-97.
[http://dx.doi.org/10.2174/156652405774641124] [PMID: 16305493]
[2]
Lee PI, Hu YL, Chen PY, Huang YC, Hsueh PR. Are children less susceptible to COVID-19. J Microbiol Immunol Infect 2020; 53(3): 371-2.
[http://dx.doi.org/10.1016j/.jmii.2020.02.011] [PMID: 32147409]
[3]
Pavone P, Giallongo A, La Rocca G, Ceccarelli M, Nunnari G. Recent COVID-19 outbreak Effect in childhood. Infect Dis & Trop Med 2020; 6e594
[4]
Menni C, Sudre CH, Steves CJ, Ourselin S, Spector TD. Quantifying additional COVID-19 symptoms will save lives. Lancet 2020; 395(10241): e107-8.
[http://dx.doi.org/10.1016/S0140-6736(20)31281-2] [PMID: 32505221]
[5]
Guarneri C, Rullo EV, Pavone P, et al. Silent COVID-19 What your skin can reveal. Lancet Infect Dis 2021; 21(1): 24-5.
[http://dx.doi.org/10.1016/S1473-3099(20)30402-3] [PMID: 32437697]
[6]
Zaladonis A, Huang S, Hsu S. COVID toes or pernio. Clin Dermatol 2020; 38(6): 764-7.
[http://dx.doi.org/10.1016j/.clindermatol.2020.06.002] [PMID: 33341212]
[7]
Sachdeva M, Gianotti R, Shah M, et al. Cutaneous manifestations of COVID-19 Report of three cases and a review of literature. J Dermatol Sci 2020; 98(2): 75-81.
[http://dx.doi.org/10.1016j/.jdermsci.2020.04.011] [PMID: 32381430]
[8]
Kolivras A, Dehavay F, Delplace D, et al. Coronavirus (COVID-19) infection-induced chilblains A case report with histopathologic findings. JAAD Case Rep 2020; 6(6): 489-92.
[http://dx.doi.org/10.1016j/.jdcr.2020.04.011] [PMID: 32363225]
[9]
West CP, Montori VM, Sampathkumar P. COVID-19 testing The threat of false-negative results. Mayo Clin Proc 2020; 95(6): 1127-9.
[http://dx.doi.org/10.1016j/.mayocp.2020.04.004] [PMID: 32376102]
[10]
Langeland N, Cox RJ. Are low SARS-CoV-2 viral loads in infected children missed by RT-PCR testing? Lancet Reg Health Eur 2021; 5: 100138.
[http://dx.doi.org/10.1016/j.lanepe.2021.100138] [PMID: 34075368]
[11]
Andina D, Noguera-Morel L, Bascuas-Arribas M, et al. Chilblains in children in the setting of COVID-19 pandemic. Pediatr Dermatol 2020; 37(3): 406-11.
[http://dx.doi.org/10.1111/pde.14215] [PMID: 32386460]
[12]
Koschitzky M, Oyola RR, Lee-Wong M, Abittan B, Silverberg N. Pediatric COVID toes and fingers. Clin Dermatol 2021; 39(1): 84-91.
[http://dx.doi.org/10.1016/j.clindermatol.2020.12.016] [PMID: 33972057]
[13]
Ruggiero G, Arcangeli F, Lotti T. Therapy for probable COVID-19 associated erythema pernio-like lesions in pediatric age. Case report. Dermatol Ther 2020; 33(4)e13616
[http://dx.doi.org/10.1111/dth.13616] [PMID: 32424851]
[14]
Mazzotta F, Troccoli T. Acute acro-ischemia in the child at the time of COVID-19. Euro Jou of ped derma 2020; 30(2): 71-4.
[15]
Piccolo V, Neri I, Filippeschi C, et al. Chilblain-like lesions during COVID-19 epidemic A preliminary study on 63 patients. J Eur Acad Dermatol Venereol 2020; 34(7): e291-3.
[http://dx.doi.org/10.1111/jdv.16526] [PMID: 32330334]
[16]
Padoan A, Sciacovelli L, Basso D, et al. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19 A longitudinal study. Clin Chim Acta 2020; 507: 164-6.
[http://dx.doi.org/10.1016/j.cca.2020.04.026] [PMID: 32343948]
[17]
Freeman EE, McMahon DE, Lipoff JB, et al. Pernio-like skin lesions associated with COVID-19 A case series of 318 patients from 8 countries. J Am Acad Dermatol 2020; 83(2): 486-92.
[http://dx.doi.org/10.1016/j.jaad.2020.05.109] [PMID: 32479979]
[18]
Zhou Z, Ren L, Zhang L, Zhong J, Xiao Y, Jia Z. Overly exuberant innate immune response to SARS-CoV-2 infection. SSRN J 2020.
[http://dx.doi.org/10.2139/ssrn.3551623]
[19]
Hadjadj J, Yatim N, Barnabei L, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 2020; 369(6504): 718-24.
[http://dx.doi.org/10.1126/science.abc6027] [PMID: 32661059]
[20]
Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 2020; 370(6515)eabd4585
[http://dx.doi.org/10.1126/science.abd4585] [PMID: 32972996]
[21]
Zhang Q, Bastard P, Liu Z, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 2020; 370(6515)eabd4570
[http://dx.doi.org/10.1126/science.abd4570] [PMID: 32972995]
[22]
Hernandez C, Bruckner AL. Focus on “COVID Toes”. JAMA Dermatol 2020; 156(9): 1003.
[http://dx.doi.org/10.1001/jamadermatol.2020.2062] [PMID: 32584385]
[23]
Kontou PI, Braliou GG, Dimou NL, Nikolopoulos G, Bagos PG. Antibody tests in detecting sars-cov-2 infection a meta-analysis. Diagnostics (Basel) 2020; 10(5)E319
[http://dx.doi.org/10.3390/diagnostics10050319] [PMID: 32438677]
[24]
Park J, Kim H, Kim SY, et al. In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients. Sci Rep 2020; 10(1): 22418.
[http://dx.doi.org/10.1038/s41598-020-80120-8] [PMID: 33376242]
[25]
Harwood R, Sinha I. Diagnosis of COVID-19 in children: the story evolves. BMC Med 2020; 18(1): 158.
[http://dx.doi.org/10.1186/s12916-020-01631-9] [PMID: 32460871]

Rights & Permissions Print Cite
Article Metrics
13
1
© 2024 Bentham Science Publishers | Privacy Policy